1. Theranostics and Nuclear Medicine, St Vincent’s Hospital, Sydney, Australia
2. Garvan Institute of Medical Research, Sydney, Australia
3. St Vincent’s Clinical School, University of New South Wales, Sydney, Australia
4. Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California
5. Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)–University Hospital Essen, Essen, Germany
6. Ahmanson Translational Theranostics, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California
7. Department of Nuclear Medicine, Kantonsspital Baden, Baden, Switzerland
8. Department of Nuclear Medicine, School of Medicine, Technical University Munich, Munich, Germany
9. Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
10. Department of Surgery, Faculty of Medicine, Monash University, Melbourne, Victoria, Australia
11. Department of Urology, Royal Brisbane and Women’s Hospital, Brisbane, Australia
12. Department of Urology, St Vincent’s Hospital Sydney, Sydney, Australia
13. Royal North Shore Hospital, Sydney, Australia
14. The Wesley Hospital, Brisbane, Australia
15. Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Department of Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer, Melbourne, Australia
16. Department of Uro-Oncology, Chris O’Brien Lifehouse, Sydney, Australia
17. Department of Radiology, St Vincent’s Hospital, Melbourne, Australia
18. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia
19. Division of Surgery and Interventional Science, University College London, London, United Kingdom